Functional hepatobiliary MR imaging in children

Anobel Tamrazi, Shreyas S. Vasanawala

Research output: Contribution to journalArticle

Abstract

Background: Clinical application efforts for the hepatocyte-specific MRI contrast agent gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) have mainly been directed toward detection and characterization of various hepatic masses in the adult population. Objective: Here we report our initial experience with Gd-EOB-DTPA for evaluating congenital and acquired hepatobiliary pathologies in the pediatric population. Materials and methods: Twenty-one consecutive children receiving Gd-EOB-DTPA for functional hepatobiliary evaluation at our institution were retrospectively identified with IRB approval. The use of Gd-EOB-DTPA was classified in each case as definite, potential, or no clinical utility, focusing on the clinical value gained beyond traditional noncontrast fluid-sensitive MR cholangiopancreatography (FS-MRCP) and other imaging modalities. Results: Definite added value of Gd-EOB-DTPA was found in 12 patients, with potential value in 4 patients, and no value in 5 patients. Benefit was seen in cases of iatrogenic and non-iatrogenic biliary strictures, perihepatic fluid collections for biliary leak, hepatobiliary dysfunction in the absence of hyperbilirubinemia, and in the functional exclusion of cystic duct occlusion that can be seen in acute cholecystitis. Conclusion: This is the first reported series of children with Gd-EOB-DTPA and this early work suggests potential pediatric applications.

Original languageEnglish (US)
Pages (from-to)1250-1258
Number of pages9
JournalPediatric Radiology
Volume41
Issue number10
DOIs
StatePublished - Oct 2011
Externally publishedYes

Fingerprint

Pentetic Acid
Gadolinium
Pediatrics
Cystic Duct
Acute Cholecystitis
Hyperbilirubinemia
Research Ethics Committees
Contrast Media
Population
Hepatocytes
Pathologic Constriction
Pathology
Liver

Keywords

  • Gadoxetate
  • Gd-EOB-DTPA
  • Hepatobiliary
  • Pediatric MR

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Pediatrics, Perinatology, and Child Health

Cite this

Functional hepatobiliary MR imaging in children. / Tamrazi, Anobel; Vasanawala, Shreyas S.

In: Pediatric Radiology, Vol. 41, No. 10, 10.2011, p. 1250-1258.

Research output: Contribution to journalArticle

Tamrazi, A & Vasanawala, SS 2011, 'Functional hepatobiliary MR imaging in children', Pediatric Radiology, vol. 41, no. 10, pp. 1250-1258. https://doi.org/10.1007/s00247-011-2086-3
Tamrazi, Anobel ; Vasanawala, Shreyas S. / Functional hepatobiliary MR imaging in children. In: Pediatric Radiology. 2011 ; Vol. 41, No. 10. pp. 1250-1258.
@article{f94b3eab550f4b2c8d2c10aaabec0a77,
title = "Functional hepatobiliary MR imaging in children",
abstract = "Background: Clinical application efforts for the hepatocyte-specific MRI contrast agent gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) have mainly been directed toward detection and characterization of various hepatic masses in the adult population. Objective: Here we report our initial experience with Gd-EOB-DTPA for evaluating congenital and acquired hepatobiliary pathologies in the pediatric population. Materials and methods: Twenty-one consecutive children receiving Gd-EOB-DTPA for functional hepatobiliary evaluation at our institution were retrospectively identified with IRB approval. The use of Gd-EOB-DTPA was classified in each case as definite, potential, or no clinical utility, focusing on the clinical value gained beyond traditional noncontrast fluid-sensitive MR cholangiopancreatography (FS-MRCP) and other imaging modalities. Results: Definite added value of Gd-EOB-DTPA was found in 12 patients, with potential value in 4 patients, and no value in 5 patients. Benefit was seen in cases of iatrogenic and non-iatrogenic biliary strictures, perihepatic fluid collections for biliary leak, hepatobiliary dysfunction in the absence of hyperbilirubinemia, and in the functional exclusion of cystic duct occlusion that can be seen in acute cholecystitis. Conclusion: This is the first reported series of children with Gd-EOB-DTPA and this early work suggests potential pediatric applications.",
keywords = "Gadoxetate, Gd-EOB-DTPA, Hepatobiliary, Pediatric MR",
author = "Anobel Tamrazi and Vasanawala, {Shreyas S.}",
year = "2011",
month = "10",
doi = "10.1007/s00247-011-2086-3",
language = "English (US)",
volume = "41",
pages = "1250--1258",
journal = "Pediatric Radiology",
issn = "0301-0449",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Functional hepatobiliary MR imaging in children

AU - Tamrazi, Anobel

AU - Vasanawala, Shreyas S.

PY - 2011/10

Y1 - 2011/10

N2 - Background: Clinical application efforts for the hepatocyte-specific MRI contrast agent gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) have mainly been directed toward detection and characterization of various hepatic masses in the adult population. Objective: Here we report our initial experience with Gd-EOB-DTPA for evaluating congenital and acquired hepatobiliary pathologies in the pediatric population. Materials and methods: Twenty-one consecutive children receiving Gd-EOB-DTPA for functional hepatobiliary evaluation at our institution were retrospectively identified with IRB approval. The use of Gd-EOB-DTPA was classified in each case as definite, potential, or no clinical utility, focusing on the clinical value gained beyond traditional noncontrast fluid-sensitive MR cholangiopancreatography (FS-MRCP) and other imaging modalities. Results: Definite added value of Gd-EOB-DTPA was found in 12 patients, with potential value in 4 patients, and no value in 5 patients. Benefit was seen in cases of iatrogenic and non-iatrogenic biliary strictures, perihepatic fluid collections for biliary leak, hepatobiliary dysfunction in the absence of hyperbilirubinemia, and in the functional exclusion of cystic duct occlusion that can be seen in acute cholecystitis. Conclusion: This is the first reported series of children with Gd-EOB-DTPA and this early work suggests potential pediatric applications.

AB - Background: Clinical application efforts for the hepatocyte-specific MRI contrast agent gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) have mainly been directed toward detection and characterization of various hepatic masses in the adult population. Objective: Here we report our initial experience with Gd-EOB-DTPA for evaluating congenital and acquired hepatobiliary pathologies in the pediatric population. Materials and methods: Twenty-one consecutive children receiving Gd-EOB-DTPA for functional hepatobiliary evaluation at our institution were retrospectively identified with IRB approval. The use of Gd-EOB-DTPA was classified in each case as definite, potential, or no clinical utility, focusing on the clinical value gained beyond traditional noncontrast fluid-sensitive MR cholangiopancreatography (FS-MRCP) and other imaging modalities. Results: Definite added value of Gd-EOB-DTPA was found in 12 patients, with potential value in 4 patients, and no value in 5 patients. Benefit was seen in cases of iatrogenic and non-iatrogenic biliary strictures, perihepatic fluid collections for biliary leak, hepatobiliary dysfunction in the absence of hyperbilirubinemia, and in the functional exclusion of cystic duct occlusion that can be seen in acute cholecystitis. Conclusion: This is the first reported series of children with Gd-EOB-DTPA and this early work suggests potential pediatric applications.

KW - Gadoxetate

KW - Gd-EOB-DTPA

KW - Hepatobiliary

KW - Pediatric MR

UR - http://www.scopus.com/inward/record.url?scp=80052583582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052583582&partnerID=8YFLogxK

U2 - 10.1007/s00247-011-2086-3

DO - 10.1007/s00247-011-2086-3

M3 - Article

C2 - 21553038

AN - SCOPUS:80052583582

VL - 41

SP - 1250

EP - 1258

JO - Pediatric Radiology

JF - Pediatric Radiology

SN - 0301-0449

IS - 10

ER -